Radiofrequency ablation as an alternative to hepatic resection for single small hepatocellular carcinomas
Authors:
- 17 November 2015
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 103 (1) , 126-135
Abstract
Background This study aimed to investigate whether radiofrequency ablation (RFA) is an alternative to surgical resection for hepatocellular carcinoma (HCC) within the context of current guidelines. Methods This retrospective study included patients with normal portal pressure and serum bilirubin level who initially underwent liver resection or RFA for a single HCC of maximum size 3 cm. Between‐group differences in cumulative rates of survival and recurrence specific for HCC were analysed in the entire cohort and in a propensity score‐matched cohort. Results A total of 604 patients were enrolled, 273 in the liver resection group and 331 in the RFA group. The 5‐ and 10‐year HCC‐specific survival rates for the resection and RFA groups were 87·6 versus 82·1 per cent and 59·0 versus 61·2 per cent respectively (P = 0·214), whereas overall 5‐ and 10‐year recurrence‐free survival rates for the corresponding groups were 60·6 versus 39·4 per cent and 37·5 versus 25·1 per cent respectively (P < 0·001). In the propensity score‐matched cohort (152 pairs), there were no differences in HCC‐specific survival (hazard ratio (HR) 1·03 for RFA versus resection; P = 0·899), whereas recurrence‐free survival again differed between the treatment groups (HR 1·75; P < 0·001). RFA was independently associated with poorer outcomes in terms of treatment‐site recurrence‐free survival (adjusted HR 1·66; P = 0·026), but not non‐treatment‐site recurrence‐free survival (adjusted HR 1·15; P = 0·354). Conclusion Although RFA carries a higher risk of treatment‐site recurrence than hepatic resection, it provides comparable overall survival in patients with a single small HCC without portal hypertension or a raised bilirubin level.Keywords
This publication has 30 references indexed in Scilit:
- Lack of Anatomical Concordance between Preablation and Postablation CT Images: A Risk Factor Related to Ablation Site RecurrenceInternational Journal of Hepatology, 2012
- The performance of different propensity score methods for estimating marginal hazard ratiosStatistics in Medicine, 2012
- A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinomaJournal of Hepatology, 2012
- Medium-Sized (3.1–5.0 cm) Hepatocellular Carcinoma: Transarterial Chemoembolization Plus Radiofrequency Ablation Versus Radiofrequency Ablation AloneAnnals of Surgical Oncology, 2011
- Management of Hepatocellular Carcinoma: An Update ΔσHepatology, 2011
- Applicability of the BCLC staging system to patients with hepatocellular carcinoma in Korea: analysis at a single center with a liver transplant centerThe Korean Journal of Hepatology, 2011
- Radiofrequency ablation of hepatocellular carcinoma: Long-term results and prognostic factors in 235 Western patients with cirrhosis #Hepatology, 2009
- Intrahepatic distant recurrence after radiofrequency ablation for a single small hepatocellular carcinoma: Risk factors and patternsJournal of Gastroenterology, 2008
- Percutaneous Ablation Procedures in Cirrhotic Patients With Hepatocellular Carcinoma Submitted to Liver TransplantationLiver Transplantation, 2005
- Prognosis of Hepatocellular Carcinoma: The BCLC Staging ClassificationSeminars in Liver Disease, 1999